Effect of Helicobacter pylori eradication on long-term survival after distal gastrectomy for gastric cancer

Cancer Research and Treatment

Volumn 48, Issue 3, 2016, Pages 1020-1029

  Kim, Young Il ^a   Cho, Soo Jeong ^a   Lee, Jong Yeul ^a   Kim, Chan Gyoo ^a   Kook, Myeong Cherl ^a   Ryu, Keun Won ^a   Kim, Young Woo ^a   Choi, Il Ju ^a  

^a National Cancer Center   (South Korea)

Author keywords

Gastrectomy; Helicobacter pylori; Stomach neoplasms; Survival

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RABEPRAZOLE; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BACTERIAL CLEARANCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISTAL GASTRECTOMY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GASTRECTOMY; GASTRIC MUCOSA; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INTENTION TO TREAT ANALYSIS; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STOMACH CANCER; ADENOCARCINOMA; AGE; DRUG EFFECTS; EPIDEMIOLOGY; GASTROENTEROSTOMY; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECOND CANCER; SEX FACTOR; STOMACH; STOMACH MUCOSA; STOMACH TUMOR; TUMOR RECURRENCE;

ADENOCARCINOMA; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS, PHASE II AS TOPIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC MUCOSA; GASTRIC STUMP; GASTROENTEROSTOMY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; STOMACH NEOPLASMS;

EID: 84981328852     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2015.264     Document Type: Article

References (25)

1. Choi IJ. Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med. 2013;28:525-37.
2. Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol. 2006;7:211-22.
3. Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, et al. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer. 2009; 115:2071-80.
4. Kang SY, Han JH, Ahn MS, Lee HW, Jeong SH, Park JS, et al. Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer. 2012;130:948-58.
5. Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382-8.
6. Qiu HB, Zhang LY, Keshari RP, Wang GQ, Zhou ZW, Xu DZ, et al. Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374.
7. Kwak HW, Choi IJ, Cho SJ, Lee JY, Kim CG, Kook MC, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol. 2014;29:1671-7.
8. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392-7.
9. Kim YI, Choi IJ, Kook MC, Cho SJ, Lee JY, Kim CG, et al. The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer. Helicobacter. 2014;19:194-201.
10. Cho SJ, Choi IJ, Kook MC, Yoon H, Park S, Kim CG, et al. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. Aliment Pharmacol Ther. 2013;38:477-89.
11. Hwang JJ, Lee DH, Kang KK, Lee AR, Yoon H, Shin CM, et al. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy. World J Gastroenterol. 2015;21: 3936-43.
12. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
13. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-23.
14. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415-9.
15. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202-9.
16. Hanada K, Graham DY. Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther. 2014;14:947-54.
17. Hobsley M, Tovey FI, Holton J. Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology. 2007;132:2076.
18. Lin YS, Chen MJ, Shih SC, Bair MJ, Fang CJ, Wang HY. Management of Helicobacter pylori infection after gastric surgery. World J Gastroenterol. 2014;20:5274-82.
19. Lee Y, Tokunaga A, Tajiri T, Masuda G, Okuda T, Fujita I, et al. Inflammation of the gastric remnant after gastrectomy: mucosal erythema is associated with bile reflux and inflammatory cellular infiltration is associated with Helicobacter pylori infection. J Gastroenterol. 2004;39:520-6.
20. Lynch DA, Mapstone NP, Clarke AM, Jackson P, Dixon MF, Quirke P, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut. 1995;36:351-3.
21. Sakakibara M, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, et al. Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant. J Gastroenterol Hepatol. 2014;29 Suppl 4:60-4.
22. Jung DH, Kim JH, Chung HS, Park JC, Shin SK, Lee SK, et al. Helicobacter pylori eradication on the prevention of metachronous lesions after endoscopic resection of gastric neoplasm: a meta-analysis. PLoS One. 2015;10:e0124725.
23. Eom BW, Lee JH, Choi IJ, Kook MC, Nam BH, Ryu KW, et al. Pretreatment risk factors for multiple gastric cancer and missed lesions. J Surg Oncol. 2012;105:813-7.
24. Nasu J, Doi T, Endo H, Nishina T, Hirasaki S, Hyodo I. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection. Endoscopy. 2005;37:990-3.
25. Bair MJ, Wu MS, Chang WH, Shih SC, Wang TE, Chen CJ, et al. Spontaneous clearance of Helicobacter pylori colonization in patients with partial gastrectomy: correlates with operative procedures and duration after operation. J Formos Med Assoc. 2009;108:13-9.